Association of insertion/deletion polymorphism of the angiotensin- converting enzyme gene with psoriasis

British Journal of Dermatology

Volumn 151, Issue 4, 2004, Pages 792-795

  Ozkur, Mehtap ^a,c   Erbagci, Z ^a   Nacak, M ^a   Tuncel, A A ^a   Alasehirli, B ^a   Aynacioglu, A S ^b  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b Epidauros Biotechnologie AG   (Germany)

^c NONE   (Turkey)

Author keywords

Angiotensin converting enzyme; Familial psoriasis; Insertion deletion polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; KININ;

ADULT; ANGIOTENSIN CONVERTING ENZYME GENE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FAMILY HISTORY; FEMALE; GENDER; GENE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; HEREDITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; ONSET AGE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSORIASIS;

ADULT; AGE OF ONSET; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PSORIASIS; SKIN DISEASES, GENETIC;

EID: 8444252134     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06148.x     Document Type: Article

References (22)

1. Ortonne JP, Recent developments in the understanding of the pathogenesis of psoriasis. Br J Dermatol 1999; 140: 1-7.
2. Barker JN. Genetic aspects of psoriasis. Clin Exp Dermatol 2001; 26: 321-5.
3. Smallridge RC, Gamblin GT, Eil C. Angiotensin-converting enzyme: characteristics in human skin fibroblasts. Metabolism 1986; 10: 899-904.
4. Petrov V, Fagard R, Lijnen P. Effect of protease inhibitors on angiotensin-converting enzyme activity in human T-lymphocytes. Am J Hypertens 2000; 13: 535-9.
5. Noveral JP, Mueller SN, Levine EM. Release of angiotensin I-converting enzyme by endothelial cells in vitro. J Cell Physiol 1987; 131: 1-5.
6. Ryder KW, Epinette WW, Jay SJ et al. Serum angiotensin-converting enzyme activity in patients with psoriasis. Clin Chim Acta 1985; 153: 143-6.
7. Coulter DM, Pillans PI. Angiotensin-converting enzyme inhibitors and psoriasis. NZ Med J 1993; 106: 392-3.
8. Wolf R, Tamir A, Brenner S. Psoriasis related to angiotensin-converting enzyme inhibitors. Dermatologica 1990; 181; 51-3.
9. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin-converting enzyme gene. Nucl Acids Res 1992; 20: 1433.
10. Carluccio M, Soccio M, De Caterina R. Aspects of gene polymorphisms in cardiovascular disease: the renin-angiotensin system. Eur J Clin Invest 2001; 31: 476-88.
11. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extraction of DNA from human nucleated cells. Nucl Acids Res 1988; 16: 1215-18.
12. Cataloluk O, Nacak M, Savas HA et al. Angiotensin converting enzyme gene polymorphism and its association to bipolar affective disorder in Turkish patients. Neurol Psych Brain Res in press.
13. Henseler T. Genetics of psoriasis. Arch Dermatol Res 1998; 290: 463-76.
14. Kundakci N, Oskay T, Olmez U et al. Association of psoriasis vulgaris with HLA class I and class II antigens in the Turkish population, according to the age at onset. Int J Dermatol 2002; 41: 345-8.
15. Schmitt-Egenolf M, Eiermann TH, Boehncke WH et al. Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DRB1*0701-DQA1*0201-DQB1 *0303: a population- and family-based study. J Invest Dermatol 1996; 106: 711-14.
16. Asadullah K, Eskdale J, Wiese A et al. Interleukin-10 promoter polymorphism in psoriasis. J Invest Dermatol 2001; 116: 975-8.
17. Marshman G, Burton JL, Archer CB. Comparison of the actions of kallidin and bradykinin in the skin of normal and psoriatic subjects. Clin Exp Dermatol 1996; 21: 112-15.
18. Campbell DJ. The kallikrein-kinin system in humans. Clin Exp Pharm Physiol 2001; 28: 1060-5.
19. Couture R, Harrisson M, Vianna RM, Cloutier F. Kinin receptors in pain and inflammation. Eur J Pharmacol 2001; 429: 161-76.
20. Schremmer-Danninger E, Hermann A, Fink E et al. Identification and occurrence of mRNAs for components of the kallikrein-kinin system in human skin and in skin diseases. Immunopharmacology 1999; 43: 287-91.
21. Poblete MT, Reynolds NJ, Figueroa CD et al. Tissue kallikrein and kininogen in human sweat glands and psoriatic skin. Br J Dermatol 1991; 124: 236-41.
22. Murphey LJ, Gainer JV, Vaughan DE, Brown NJ. Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin. Circulation 2000; 102: 829-32.